cbdMD
YCBD

$0.58

3.53%

Market Cap: 2.24M

About: cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Employees: 52

Materials Perfumes, Cosmetics & Other Toilet Preparations

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

3.81% less ownership

Funds ownership: 7.37% [Q4 2023] → 3.56% (-3.81%) [Q1 2024]

29% less funds holding

Funds holding: 24 [Q4 2023] → 17 (-7) [Q1 2024]

55% less capital invested

Capital invested by funds: $227K [Q4 2023] → $101K (-$125K) [Q1 2024]

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for YCBD.

See Analyst Rankings

Financial journalist opinion

cbdMD Announces Publication of Human Clinical Trial Data

Charlotte, North Carolina--(Newsfile Corp. - June 27, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading providers of premium cannabidiol (CBD) products, today announced the publication of the Company's human clinical trial data demonstrating the benefits of its proprietary Broad Spectrum CBD blend. The data was published in the Journal of the International Society of Sports Nutrition.

cbdMD Announces Publication of Human Clinical Trial Data

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) ,one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated June 5, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the "Company Guide").

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes

There's bad news brewing for some cannabis stocks. Even as cannabis rescheduling efforts continue, a key segment of the wider market is coming up on massive disruption: a hemp ban.

Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes

cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions

Charlotte, North Carolina--(Newsfile Corp. - May 24, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company") is thrilled to announce the launch of its highly anticipated ATRx Labs Premium Mushroom Line, available exclusively at GNC stores nationwide. Crafted with a blend of powerful mushroom extracts, derived from the fruiting bodies of the mushrooms and complimented by clinically studied ingredients, these supplements are designed to cater to a wide array of health needs for consumers across the nation.

cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions

cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer

Charlotte, North Carolina--(Newsfile Corp. - May 16, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) a leading name in premium CBD offerings, is excited to introduce its newest relaxation innovation: "Max Chill" Dragon Fruit D9 Gummies. Crafted to elevate your summer unwind sessions, these gummies boast a distinctive 1:1 CBD to THC ratio, marking a milestone in the brand's selection of high-mg THC products.

cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer

cbdMD Reports Second Quarter Results

cbdMD's new line of functional mushroom products, ATRx, launches into national retailer Charlotte, North Carolina--(Newsfile Corp. - May 15, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs today announced its financial results for the March 31, 2024 second quarter of fiscal 2024 year end. While year-over-year operational losses showed a slight increase from $1.4 million in the second quarter of fiscal 2023 ending March 31, 2023 to $1.5 million in second fiscal quarter 2024, management believes recently implemented expense reductions are poised to generate significant savings in the second half of the fiscal year.

cbdMD Reports Second Quarter Results

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

Charlotte, North Carolina--(Newsfile Corp. - May 13, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Wednesday, May 15, 2024, to discuss the company's March 31, 2024 second quarter of fiscal 2024 financial results and business progress.

cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

cbdMD leads with Strategic Improvements and is Building Momentum with ATRx Line Charlotte, North Carolina--(Newsfile Corp. - February 13, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands - its flagship brand cbdMD, its animal health brand Paw CBD, today announced our financial results for our first quarter of fiscal 2024 ending December 31, 2023. For the first quarter of Fiscal 2024, we continued to make strong year over year progress on our turnaround.

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

Charlotte, North Carolina--(Newsfile Corp. - February 8, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, February 13, 2024, to discuss the company's December 31, 2023 first quarter of fiscal 2024 financial results and business progress.

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth

Charlotte, North Carolina--(Newsfile Corp. - February 8, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBD-PA) (the "Company"), one of the nation's leading and most trusted CBD companies, proudly announces the appointment of Joe Baghadjian as Vice President of Wholesale Sales. The addition of Joe Baghadjian to the cbdMD team brings a wealth of expertise and a unique skill set to the cbdMD.

cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth

See News Rankings